Apitope
Apitope aims to bounce back from MS setback
Richard Staines
Apitope, Biogen, Merck KGaA, multiple sclerosis, neurology
0 Comment
Biotech looks for funding and long-term development partner
X
Apitope aims to bounce back from MS setback
https://pharmaphorum.com/news/apitope-aims-bounce-back-ms-setback/
Apitope to develop MS drug, Merck KGaA tie-up ends
Richard Staines
Apitope, Biotech, Merck KGaA, multiple sclerosis, neurology, R&D
0 Comment
Anglo-Belgian biotech will continue clinical development.
X
Apitope to develop MS drug, Merck KGaA tie-up ends
https://pharmaphorum.com/news/apitope-develop-ms-drug-merck-kgaa-tie-ends/